Today: 20 May 2026
Broadcom (AVGO) stock: What to watch after Friday’s 3.8% surge and a fresh $480 target
11 January 2026
2 mins read

Broadcom (AVGO) stock: What to watch after Friday’s 3.8% surge and a fresh $480 target

New York, Jan 11, 2026, 10:01 EST — The market has closed.

  • Shares of Broadcom rose 3.76% on Friday, closing at $344.97 after slipping the day before.
  • A Mizuho analyst boosted his price target for Broadcom to $480, maintaining an Outperform rating.
  • Tuesday’s U.S. CPI report and the initial batch of earnings are now in investors’ sights for clues on market direction.

Broadcom (AVGO) shares climbed 3.76% Friday, closing at $344.97 after dropping 3.21% the previous session. The chip stock bounced back in a weekend rally, trading between $333.50 and $347.39 with roughly 22.5 million shares changing hands.

Broadcom’s rally helped push the S&P 500 to a fresh high, with chip stocks leading the charge as investors doubled down on the AI theme. The PHLX semiconductor index surged 2.7%, hitting a new peak. Meanwhile, a softer-than-expected U.S. jobs report failed to dent hopes for Fed rate cuts later this year. The Supreme Court also held off on ruling the legality of President Donald Trump’s tariffs, leaving another big macro question unresolved. “Investors are getting granular and picking the winners and losers,” said Zachary Hill, head of portfolio management at Horizon Investments. Reuters

That combination puts Broadcom right back where it’s often seen: a big, liquid chip stock tied to AI that traders watch closely as a gauge of risk appetite — and sometimes use to hedge it. With the market shut on Sunday, the next real test arrives when cash trading kicks off Monday.

Fresh analyst updates helped spark the late-week rally. Vijay Rakesh at Mizuho lifted his price target on Broadcom to $480 from $450, keeping an Outperform rating that suggests the stock will outperform the market. His bullish stance fits into a wider 2026 semiconductor outlook. Rakesh highlighted “attractive valuations,” though he cautioned upside might be less dramatic than last year’s surge. TipRanks

Separately, Broadcom’s infrastructure group president, Ram Velaga, submitted an initial beneficial ownership statement as an officer. The filing details his holdings in common stock alongside performance stock units, which vest only if certain share-price targets are met.

The broader market keeps shuffling. Nathan Peterson at Charles Schwab noted, “It appears 2026 will be a ‘stock pickers’ market,’” pointing out that the chip index’s recent peak owes more to gains in equipment and memory stocks than the typical 2025 frontrunners like Broadcom. Schwab Brokerage

Inflation takes center stage this week. The U.S. Consumer Price Index (CPI) drops Tuesday, Jan. 13, with retail sales and the Producer Price Index (PPI) following later. Fed officials are also scheduled to speak throughout the week. These data points are key for semiconductors, as chip stocks often move like rate-sensitive plays when bond yields shift.

Earnings season is heating up as major U.S. banks prepare to start reporting. Taiwan Semiconductor is set to release its results Thursday, a key indicator for chip demand and supply that often influences U.S.-listed counterparts.

For Broadcom, all eyes are on whether Friday’s climb above the mid-$340s sticks and if buying interest expands past the usual AI favorites. Analyst updates could also move the needle, given the stock’s recent moves have been driven more by expectations than actual news.

But the setup works both ways. A hotter CPI print might drive yields higher, putting pressure on richly valued tech and chip stocks. The unresolved tariff situation can also trigger rapid risk repricing if new policy headlines emerge. Even within AI, investors have shown they’re quick to pivot when margins or demand assumptions change.

Traders are zeroing in on Tuesday’s CPI report, due Jan. 13, and TSMC’s earnings due Jan. 15. They want to see if the chip rally that pushed Broadcom higher into Friday’s close can keep its momentum when U.S. markets open again.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Rocket Companies stock jumps nearly 10% on Trump’s $200B mortgage-bond plan — what to watch next
Previous Story

Rocket Companies stock jumps nearly 10% on Trump’s $200B mortgage-bond plan — what to watch next

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape
Next Story

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape

Go toTop